Comparison of clinical characteristics and prognostic factors of combined pulmonary fibrosis and emphysema versus idiopathic pulmonary fibrosis alone

Respirology

Volumn 19, Issue 2, 2014, Pages 239-245

  Sugino, Keishi ^a   Ishida, Fumiaki ^a   Kikuchi, Naoshi ^a   Hirota, Nao ^a   Sano, Go ^a   Sato, Keita ^a   Isobe, Kazutoshi ^a   Sakamoto, Susumu ^a   Takai, Yujiro ^a   Homma, Sakae ^a  

^a TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

Author keywords

combined pulmonary fibrosis and emphysema; Doppler echocardiography; idiopathic pulmonary fibrosis; prognostic factor; pulmonary emphysema

Indexed keywords

SURFACTANT PROTEIN D;

AGED; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; DYSPNEA; EMPHYSEMA; FEMALE; FIBROSING ALVEOLITIS; FORCED EXPIRATORY VOLUME; HOSPITAL ADMISSION; HUMAN; LUNG ARTERY PRESSURE; LUNG CANCER; LUNG FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SURVIVAL RATE; SURVIVAL TIME; VERY ELDERLY; COMPARATIVE STUDY; COMPLICATION; DISEASE COURSE; IDIOPATHIC PULMONARY FIBROSIS; PROPORTIONAL HAZARDS MODEL; PULMONARY EMPHYSEMA; RETROSPECTIVE STUDY;

AGED; DISEASE PROGRESSION; FEMALE; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; MALE; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PULMONARY EMPHYSEMA; RETROSPECTIVE STUDIES;

EID: 84892587225     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12207     Document Type: Article

References (20)

1. Lettieri CJ, Nathan SD, Barnett SD, Ahmad S, Shorr AF,. Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 2006; 129: 746-752.
2. Hamada K, Nagai S, Tanaka S, Handa T, Shigematsu M, Nagao T, Mishima M, Kitaichi M, Izumi T,. Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis. Chest 2007; 131: 650-656.
3. Mejía M, Carrillo G, Rojas-Serrano J, Estrada A, Suárez T, Alonso D, Barrientos E, Gaxiola M, Navarro C, Selman M,. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest 2009; 136: 10-15.
4. Cottin V, Nunes H, Brillet PY, Delaval P, Devouassoux G, Tillie-Leblond I, Israel-Biet D, Court-Fortune I, Valeyre D, Cordier JF, Groupe d'Etude et de Recherche sur les Maladies Orphelines Pulmonaires (GERM O P). Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur. Respir. J. 2005; 26: 586-593.
5. Akagi T, Matsumoto T, Harada T, Tanaka M, Kuraki T, Fujita M, Watanabe K,. Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis. Respir. Med. 2009; 103: 1209-1215.
6. American Thoracic Society. Idiopathic pulmonary fibrosis: diagnosis and treatment. International consensus statement-American Thoracic Society (ATS), and the European Respiratory Society (ERS). Am. J. Respir. Crit. Care Med. 2000; 161: 646-664.
7. Kondoh Y, Taniguchi H, Katsuta T, Kataoka K, Kimura T, Nishiyama O, Sakamoto K, Johkoh T, Nishimura M, Ono K, et al. Risk factors of acute exacerbation of idiopathic pulmonary fibrosis. Sarcoidosis Vasc. Diffuse Lung Dis. 2010; 27: 103-110.
8. Japanese Respiratory Society's Committee Formulating Diagnosis and Treatment Guideline for Diffuse Lung Diseases. Clinical Diagnostic and Treatment Guidance for Idiopathic Interstitial Pneumonia. Nankodo, Tokyo, 2004.
9. Brinkman GL, Coates EO Jr,. The effect of bronchitis, smoking and occupation on ventilation. Annu. Rev. Respir. Dis. 1963; 87: 684-693.
10. Goddard PR, Nicholson EM, Laszlo G, Watt I,. Computed tomography in pulmonary emphysema. Clin. Radiol. 1982; 33: 379-387.
11. Sumikawa H, Johkoh T, Colby TV, Ichikado K, Suga M, Taniguchi H, Kondoh Y, Ogura T, Arakawa H, Fujimoto K, et al. Computed tomography findings in pathological usual interstitial pneumonia: relationship to survival. Am. J. Respir. Crit. Care Med. 2008; 177: 433-439.
12. Standardization of Spirometry, 1994 update: American Thoracic Society. Am. J. Respir. Crit. Care Med. 1995; 152: 1107-1136.
13. Wells AU, Desai SR, Rubens MB, Goh NS, Cramer D, Nicholson AG, Colby TV, du Bois RM, Hansell DM,. Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am. J. Respir. Crit. Care Med. 2003; 167: 962-969.
14. Ryerson CJ, Hartman T, Elicker BM, Ley B, Lee JS, Abbritti M, Jones KD, King TE, Ryu J, Collard HR,. Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis. Chest 2013; 144: 234-240.
15. Kitaguchi Y, Fujimoto K, Hanaoka M, Kawakami S, Honda T, Kubo K,. Clinical characteristics of combined pulmonary fibrosis and emphysema. Respirology 2010; 15: 265-271.
16. Kurashima K, Takayanagi N, Tsuchiya N, Kanauchi T, Ueda M, Hoshi T, Miyahara Y, Sugita Y,. The effect of emphysema on lung function and survival in patients with idiopathic pulmonary fibrosis. Respirology 2010; 15: 843-848.
17. Todd NW, Jeudy J, Lavania S, Franks TJ, Galvin JR, Deepak J, Britt EJ, Atamas SP,. Centrilobular emphysema combined with pulmonary fibrosis results in improved survival. Fibrogenesis Tissue Repair 2011; 4: 6. doi: 10.1186/1755-1536-4-6.
18. Atamas SP,. Complex cytokine regulation of tissue fibrosis. Life Sci. 2002; 72: 631-643.
19. Arcasoy SM, Christie JD, Ferrari VA, Sutton MS, Zisman DA, Blumenthal NP, Pochettino A, Kotloff RM,. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am. J. Respir. Crit. Care Med. 2003; 167: 735-740.
20. Schmidt SL, Nambiar AM, Tayob N, Sundaram B, Han MK, Gross BH, Kazerooni EA, Chughtai AR, Lagstein A, Myers JL, et al. Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema. Eur. Respir. J. 2011; 38: 176-183.